<p>During the follow-up time, no patient with MH underwent surgery as compared to 10 patients without MH (logrank p = 0.03).</p
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>Patients were followed up to one year after surgery. After 12 months 103 (15.8%) patients had die...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>During the follow-up time, 3 patients with MH underwent surgery as compared to 31 patients withou...
<p>In the TNF1 group, 146 patients (72.3%) had no MH, while 56 patients (27.7%) had MH. In the TNF2 ...
<p>(Patients who did not have tumor measurements at the time of last follow-up (N = 9) or patients w...
<p>Patient’s postoperative Kaplan-Meir survival curves in conventional and piggyback groups (p = 0.3...
<p>Kaplan-Meier analysis of the recurrence-free survival rates of patients with and without antitumo...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection (TUR) of ...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection(TUR) of t...
<p>6-year follow-up after operation, 66 patients randomized between a Standard or Restricted intraop...
<p>(<b>A</b>) Kaplan-Meier estimates of recurrence-free survival in all NMIBC patients grouped by th...
<p>(a) overall survival; (b) locoregional relapse-free survival; (c) distant metastasis-free surviva...
<p>Kaplan-Meier curves indicate that there are significant differences in recurrence-free survival b...
<p>Kaplan-Meier curves for relapse-free survival and overall survival after surgery.</p
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>Patients were followed up to one year after surgery. After 12 months 103 (15.8%) patients had die...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>During the follow-up time, 3 patients with MH underwent surgery as compared to 31 patients withou...
<p>In the TNF1 group, 146 patients (72.3%) had no MH, while 56 patients (27.7%) had MH. In the TNF2 ...
<p>(Patients who did not have tumor measurements at the time of last follow-up (N = 9) or patients w...
<p>Patient’s postoperative Kaplan-Meir survival curves in conventional and piggyback groups (p = 0.3...
<p>Kaplan-Meier analysis of the recurrence-free survival rates of patients with and without antitumo...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection (TUR) of ...
<p>Kaplan-Meier estimates of progression-free survival rates after transurethral resection(TUR) of t...
<p>6-year follow-up after operation, 66 patients randomized between a Standard or Restricted intraop...
<p>(<b>A</b>) Kaplan-Meier estimates of recurrence-free survival in all NMIBC patients grouped by th...
<p>(a) overall survival; (b) locoregional relapse-free survival; (c) distant metastasis-free surviva...
<p>Kaplan-Meier curves indicate that there are significant differences in recurrence-free survival b...
<p>Kaplan-Meier curves for relapse-free survival and overall survival after surgery.</p
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
<p>Patients were followed up to one year after surgery. After 12 months 103 (15.8%) patients had die...
<p>Kaplan-Meier estimates of recurrence-free survival rates after transurethral resection (TUR) of t...
DOI
Add to ORKG